Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

MMP/TNF inhibitors reported by Pfizer

Dec. 12, 1996

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Another British Biotech compound reaches clinical stage

Dec. 9, 1996

FDA tentatively approves generic NSAID

Dec. 6, 1996

SKB, IDEC initiate phase III testing of antirheumatic antibody

Dec. 6, 1996

Connective Therapeutics acquires rheumatoid arthritis Rx from SKB

Dec. 6, 1996

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Dec. 5, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...